Replies to post #88667 on Biotech Values

[genisi]

I think that many docs are waiting for outcomes data of Tekturna and its class.

[poorgradstudent]

>For people who don’t benefit from the ACE/ARB classes and are looking to combat hypertension only, I would think Tekturna might be a better option<

Same pathway... ;-)